BioSpace News Archive

The approval of Keytruda also now includes stage III melanoma following complete resection for pediatric patients 12 years and up.

Austin, Texas-based Aeglea Biotherapeutics reported what initially appears to be positive outcomes for its Phase III PEACE trial of pegzilarginase in Arginase 1 Deficiency (ARG1-D).

ADI-001 generated positive early responses from three of four evaluable participants, two of whom achieved complete responses while one had a partial response that researchers logged as “near complete.”

Surrozen’s ethos is “CLIMB ON”. This catchy and focus-appropriate acronym stands for Collaborate, Lead, Innovate, Motivate and be Brave, Open and Nurturing.

Acetabular system is a highly flexible solution that provides the ability to treat patients suffering from orthopedic diseases. Acetabular cup is a type of implant that is placed in hip sockets.

Hummingbird Bioscience and Cancer Research UK announced that the first patient has been dosed in a Phase 1 clinical trial of HMBD-001 for the treatment of patients with advanced HER3-expressing solid malignancies.

MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking place from December 13-16, 2021.

Bolt Biotherapeutics, Inc. announced the presentation of interim clinical data from the company’s ongoing Phase 1/2 study of BDC-1001, the company’s lead immune-stimulating antibody conjugate in a poster session at the European Society for Medical Oncology Immuno-Oncology Congress 2021, being held virtually from Dec. 6-11, 2021.

Matinas BioPharma Holdings, Inc. today announced the appointment of Thomas Hoover to the newly created position of Chief Business Officer.

Bright Minds Biosciences today announced that Ian McDonald, Chief Executive Officer, will present virtually at the Stifel GMP 2nd Annual Future of Healthcare Conference as follows: Date: Wednesday, December 8, 2021 Time: 3:00PM.